Kathryn Andrews

Chief Financial Officer & Company Secretary

Ms. Andrews is a highly experienced biotechnology CFO with both ASX and Nasdaq experience most recently with Alterity Therapeutics. Ms. Andrews was appointed as their CFO in November 2014. Between 2012 and 2014, Ms. Andrews held a senior role with The CFO Solution, a firm focused on providing an outsourced CFO team including company secretarial to listed public companies, mainly in the biotechnology sector. Between 2002 and 2006, Ms. Andrews was the CFO and Company Secretary of Antisense Therapeutics Limited.

Ms. Andrews also provided contract accounting, governance and consulting services to various mining and resources, technology, and government organizations from 2007 to 2012 and 1999 to 2002. Between 1989 and 1998, Ms. Andrews was employed by Rio Tinto Limited in a variety of accounting, internal audit, and financial management roles. Ms. Andrews holds a Bachelor of Commerce from the University of Melbourne, is a Certified Practicing Accountant, a Fellow of the Governance Institute of Australia, and a Member of the Australian Institute of Company Directors.